{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:04:49Z","timestamp":1779894289555,"version":"3.53.1"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"iCo Therapeutics Inc."}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,10,20]]},"abstract":"<jats:p>The purpose of this study was to assess the safety, tolerability, pharmacokinetics (PK), and biodistribution of novel oral amphotericin B (AmpB) formulations following single- and multiple-oral-dose administration to healthy beagle dogs. The liquid formulation of AmpB was administered to three male dogs, and the capsule formulations of AmpB were administered to each of two groups of six male dogs. Blood was collected for pharmacokinetic evaluation on days 1, 2, and 3 (up to 72\u2009h postdosing).<\/jats:p>","DOI":"10.1128\/aac.01111-20","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T13:02:36Z","timestamp":1597323756000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle Dogs"],"prefix":"10.1128","volume":"64","author":[{"given":"Kishor M.","family":"Wasan","sequence":"first","affiliation":[{"name":"iCo Therapeutics Inc., Vancouver, British Columbia, Canada"},{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen K.","family":"Wasan","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hnik","sequence":"additional","affiliation":[{"name":"iCo Therapeutics Inc., Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200311130812"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11030099"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2017.1380664"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/10837450.2018.1515225"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2016.1228715"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-3084(96)02652-7"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.05.013"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.03.013"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.08.042"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2012.02.008"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp140"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000913"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/600105"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425240902802861"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01293-15"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2012.10.003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.07.035"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0538-7"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1996.tb01348.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.1047-1050.2004"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-015-0267-6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.891271"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S95194"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.05.044"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.01.023"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-017-0452-x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/564573"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2013.04.053"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir735"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr002"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-012-9876-2"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp500527x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/08982100009031116"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2704-2707.2002"},{"key":"e_1_3_2_36_2","first-page":"2681","article-title":"Oral administration of amphotericin B: toxicokinetic studies in animal models","volume":"12","author":"Kalbag S","year":"1992","unstructured":"Kalbag S, Lu R, Ngoje J, Mannino RJ. 1992. Oral administration of amphotericin B: toxicokinetic studies in animal models. Antimicrob Agents Chemother 12:2681\u20132685.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_2_37_2","unstructured":"Matinas Biopharma. 2018. MAT2203: LNC formulation of amphotericin B. https:\/\/www.matinasbiopharma.com\/pipeline\/mat2203-lnc-formulation-of-amphotericin-b. Accessed 15 September 2018."},{"key":"e_1_3_2_38_2","unstructured":"Mannino R De B Teae A. Oral administration of amphotericin B (CAmB) in humans: a phase I study of tolerability and pharmacokinetics preliminary pharmacokinetics. https:\/\/content.equisolve.net\/_db6027646f523d19fe795801a0b7aff1\/matinasbiopharma\/db\/128\/510\/pdf\/Oral_Dosing_of_Encochleated_Amphotericin_B_%28CAmB%29__Rapid_Drug_Targeting_to_Infected_Tissues_in_Mice_with_Invasive_Candidiasis.pdf. Accessed 21 February 2019."},{"key":"e_1_3_2_39_2","unstructured":"Kalbag S Ruying L Ngoje J Mannino RJ. 2009. Oral administration of amphotericin B: toxicokinetic studies in animal models. Scientific Presentations & Publications Matinas Biopharma 2009. https:\/\/d1io3yog0oux5.cloudfront.net\/_8b84b59e9151ca6f4fb2e97ac3cfd9f8\/matinasbiopharma\/db\/284\/2327\/pdf\/CAmB-Focus-Tox-Poster.pdf. Accessed 22 April 2020."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003169"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-10-135"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.26.4.446"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01450-20"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.36.2.299"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199005020-00003"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.01.003"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01111-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01111-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:34:15Z","timestamp":1645479255000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01111-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10,20]]}},"alternative-id":["10.1128\/AAC.01111-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01111-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"2020-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01111-20"}}